Home › Jefferies Group Reiterates Hold Rating for Gilead Sciences, Inc.
 

Keywords :   


Jefferies Group Reiterates Hold Rating for Gilead Sciences, Inc.

2016-03-27 07:36:47| Biotech - Topix.net

's stock had its "hold" rating reiterated by investment analysts at Jefferies Group in a report issued on Monday, Market Beat Ratings reports. They currently have a $97.00 price target on the biopharmaceutical company's stock, down from their prior price target of $100.00.

Tags: inc group rating hold

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05Panasonic offers Fire TV, Google TV and Powered by TiVo
20.05Eutelsat reports results for the period ended 31 March 2024
20.05WCC Re-elects Tom Bowtell for Second Term as President, Recognizes Contributions of Andy Doyle
20.05May/June 2024 Digital Edition of National Hog Farmer now available
20.05DKSH Extends Distribution Agreement with KRONOS in Asia Pacific
20.05NABC hosts foreign animal disease tabletop exercise
20.05NABC hosts foreign animal disease tabletop exercise
20.05Printed Easy increases capacity by 300% with Durst
More »